Gary Borodic

Summary

Publications

  1. doi request reprint Drug-induced graves disease from CTLA-4 receptor suppression
    Gary Borodic
    Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02142, USA
    Ophthal Plast Reconstr Surg 27:e87-8. 2011
  2. doi request reprint Use of fillers as adjunct therapy for the treatment of lower face hemifacial spasm
    Gary E Borodic
    Harvard Medical School, Ophthalmology Massachusetts Eye and Ear Infirmary, Quincy, Massachusetts 02169, USA
    Ophthal Plast Reconstr Surg 29:225-6. 2013
  3. ncbi request reprint Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects
    G E Borodic
    Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA
    Expert Opin Investig Drugs 10:1531-44. 2001
  4. ncbi request reprint Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications
    Gary Borodic
    Massachusetts Eye and Ear Infirmary, Cambridge, MA, USA
    Facial Plast Surg Clin North Am 15:11-6, v. 2007
  5. ncbi request reprint Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints
    Gary Borodic
    Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA
    Plast Reconstr Surg 116:36-43. 2005
  6. ncbi request reprint Immunologic resistance after repeated botulinum toxin type a injections for facial rhytides
    Gary Borodic
    Ophthal Plast Reconstr Surg 22:239-40. 2006

Detail Information

Publications6

  1. doi request reprint Drug-induced graves disease from CTLA-4 receptor suppression
    Gary Borodic
    Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02142, USA
    Ophthal Plast Reconstr Surg 27:e87-8. 2011
    ..The combination of these observations suggests CTLA-4 mediated T-cell functions are important to the pathogenesis of thyroid-associated eye disease...
  2. doi request reprint Use of fillers as adjunct therapy for the treatment of lower face hemifacial spasm
    Gary E Borodic
    Harvard Medical School, Ophthalmology Massachusetts Eye and Ear Infirmary, Quincy, Massachusetts 02169, USA
    Ophthal Plast Reconstr Surg 29:225-6. 2013
    ..The conventional filler effect also further reduces asymmetric nasolabial folds and marionette lines. Fifteen of 18 patients with lower facial spasms found the filler toxin combination an improvement over neurotoxin alone...
  3. ncbi request reprint Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects
    G E Borodic
    Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA
    Expert Opin Investig Drugs 10:1531-44. 2001
    ..The mechanisms of BTX formulations acting on SNARE proteins are briefly reviewed providing a basis for BTX clinical applications. The potential for design of improved botulinum toxins and formulations is addressed...
  4. ncbi request reprint Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications
    Gary Borodic
    Massachusetts Eye and Ear Infirmary, Cambridge, MA, USA
    Facial Plast Surg Clin North Am 15:11-6, v. 2007
    ..An individual who is injected with botulinum toxin for cosmetic purposes could someday require an effective form of type A toxin for dystonia, pain, or spasticity...
  5. ncbi request reprint Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints
    Gary Borodic
    Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA
    Plast Reconstr Surg 116:36-43. 2005
    ....
  6. ncbi request reprint Immunologic resistance after repeated botulinum toxin type a injections for facial rhytides
    Gary Borodic
    Ophthal Plast Reconstr Surg 22:239-40. 2006